Matches in SemOpenAlex for { <https://semopenalex.org/work/W2133203314> ?p ?o ?g. }
- W2133203314 abstract "Soft tissue sarcomas are uncommon malignancies with few therapeutic options for recurrent or metastatic disease. Dolastatin-10 (Dol-10) is a pentapeptide anti-microtubule agent that binds to tubulin sites distinct from vinca alkaloids. Based on the novel mechanism of action, limited activity of other anti-microtubular agents, and anti-neoplastic activity in pre-clinical screening of Dol-10, this multi-institutional phase II study was conducted to determine the objective response rate of Dol-10 in recurrent or metastatic soft tissue sarcomas that had not been treated with chemotherapy outside of the adjuvant setting.Dol-10 was given intravenously at a dose of 400 mug/m(2) and repeated every 21 days. Toxicities were assessed using the Common Toxicity Criteria (version 2.0). Radiographic studies and tumor measurements were repeated every two cycles to assess response [Miller AB, et al. Cancer 1981; 47(1): 207].Dol-10 was associated with hematological toxicity and with some vascular toxicities. There was no significant gastrointestinal, hepatic or renal toxicity. There was one death on study due to respiratory failure. There were no objective responses in 12 patients treated with Dol-10.Based on this phase II trial, further study of Dol-10 on this schedule is not recommended in advanced or metastatic soft tissue sarcomas." @default.
- W2133203314 created "2016-06-24" @default.
- W2133203314 creator A5003417999 @default.
- W2133203314 creator A5033270447 @default.
- W2133203314 creator A5042275854 @default.
- W2133203314 creator A5071305709 @default.
- W2133203314 creator A5076091049 @default.
- W2133203314 creator A5076620546 @default.
- W2133203314 creator A5085336500 @default.
- W2133203314 creator A5086393033 @default.
- W2133203314 creator A5090472587 @default.
- W2133203314 date "2004-01-01" @default.
- W2133203314 modified "2023-09-23" @default.
- W2133203314 title "Phase II Trial of Dolastatin-10, a Novel Anti-Tubulin Agent, in Metastatic Soft Tissue Sarcomas." @default.
- W2133203314 cites W1543933515 @default.
- W2133203314 cites W1589293594 @default.
- W2133203314 cites W181928761 @default.
- W2133203314 cites W1849457428 @default.
- W2133203314 cites W1867232617 @default.
- W2133203314 cites W1943427806 @default.
- W2133203314 cites W1980723168 @default.
- W2133203314 cites W1981129666 @default.
- W2133203314 cites W1994162165 @default.
- W2133203314 cites W2000753870 @default.
- W2133203314 cites W2002215444 @default.
- W2133203314 cites W2004385676 @default.
- W2133203314 cites W2017167372 @default.
- W2133203314 cites W2021484735 @default.
- W2133203314 cites W2037096332 @default.
- W2133203314 cites W2041094673 @default.
- W2133203314 cites W2045612610 @default.
- W2133203314 cites W2047718354 @default.
- W2133203314 cites W2048628775 @default.
- W2133203314 cites W2056749393 @default.
- W2133203314 cites W2069713536 @default.
- W2133203314 cites W2079088649 @default.
- W2133203314 cites W2083318374 @default.
- W2133203314 cites W2085480583 @default.
- W2133203314 cites W2123058403 @default.
- W2133203314 cites W2167805334 @default.
- W2133203314 cites W2170806279 @default.
- W2133203314 cites W2199864370 @default.
- W2133203314 cites W2268003579 @default.
- W2133203314 cites W2300939161 @default.
- W2133203314 cites W2943632939 @default.
- W2133203314 doi "https://doi.org/10.1080/13577140400009163" @default.
- W2133203314 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2395616" @default.
- W2133203314 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18521404" @default.
- W2133203314 hasPublicationYear "2004" @default.
- W2133203314 type Work @default.
- W2133203314 sameAs 2133203314 @default.
- W2133203314 citedByCount "5" @default.
- W2133203314 countsByYear W21332033142012 @default.
- W2133203314 countsByYear W21332033142015 @default.
- W2133203314 countsByYear W21332033142017 @default.
- W2133203314 countsByYear W21332033142018 @default.
- W2133203314 crossrefType "journal-article" @default.
- W2133203314 hasAuthorship W2133203314A5003417999 @default.
- W2133203314 hasAuthorship W2133203314A5033270447 @default.
- W2133203314 hasAuthorship W2133203314A5042275854 @default.
- W2133203314 hasAuthorship W2133203314A5071305709 @default.
- W2133203314 hasAuthorship W2133203314A5076091049 @default.
- W2133203314 hasAuthorship W2133203314A5076620546 @default.
- W2133203314 hasAuthorship W2133203314A5085336500 @default.
- W2133203314 hasAuthorship W2133203314A5086393033 @default.
- W2133203314 hasAuthorship W2133203314A5090472587 @default.
- W2133203314 hasConcept C126322002 @default.
- W2133203314 hasConcept C136948725 @default.
- W2133203314 hasConcept C142724271 @default.
- W2133203314 hasConcept C143998085 @default.
- W2133203314 hasConcept C2776694085 @default.
- W2133203314 hasConcept C2777096885 @default.
- W2133203314 hasConcept C2778629024 @default.
- W2133203314 hasConcept C29730261 @default.
- W2133203314 hasConcept C31760486 @default.
- W2133203314 hasConcept C535046627 @default.
- W2133203314 hasConcept C71924100 @default.
- W2133203314 hasConcept C90924648 @default.
- W2133203314 hasConcept C98274493 @default.
- W2133203314 hasConceptScore W2133203314C126322002 @default.
- W2133203314 hasConceptScore W2133203314C136948725 @default.
- W2133203314 hasConceptScore W2133203314C142724271 @default.
- W2133203314 hasConceptScore W2133203314C143998085 @default.
- W2133203314 hasConceptScore W2133203314C2776694085 @default.
- W2133203314 hasConceptScore W2133203314C2777096885 @default.
- W2133203314 hasConceptScore W2133203314C2778629024 @default.
- W2133203314 hasConceptScore W2133203314C29730261 @default.
- W2133203314 hasConceptScore W2133203314C31760486 @default.
- W2133203314 hasConceptScore W2133203314C535046627 @default.
- W2133203314 hasConceptScore W2133203314C71924100 @default.
- W2133203314 hasConceptScore W2133203314C90924648 @default.
- W2133203314 hasConceptScore W2133203314C98274493 @default.
- W2133203314 hasLocation W21332033141 @default.
- W2133203314 hasOpenAccess W2133203314 @default.
- W2133203314 hasPrimaryLocation W21332033141 @default.
- W2133203314 hasRelatedWork W1589293594 @default.
- W2133203314 hasRelatedWork W1770304167 @default.
- W2133203314 hasRelatedWork W181472673 @default.
- W2133203314 hasRelatedWork W1968195969 @default.
- W2133203314 hasRelatedWork W1981558181 @default.